Skip to main content

Table 1 Demographic Characteristics of Survey Respondents

From: Clinical leaders and providers’ perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs’ facilities

  Baseline (n = 56) Follow-up (n = 61)  
n % n % p-valuea
Survey Response per regional network, Mdn (Range) 3 1–7 3 0–8  
Age:      0.92
 25–34 11 19.6 11 18.6  
 35–44 20 35.7 18 30.5  
 45–54 12 21.4 15 25.4  
 55–64 9 16.1 12 20.3  
 65 +  4 7.1 3 5.1  
Gender:      0.81
 Female 33 58.9 34 56.7  
 Male 23 41.1 26 43.3  
Total years of practice:      0.70
 ≤ 5 9 16.1 6 9.8  
 5–10 14 25.0 19 31.1  
 11–20 15 26.8 18 29.5  
 20 +  18 32.1 18 29.5  
Race/Ethnicity:      0.52
 Asian 9 16.4 7 11.7  
 Black or African American 5 9.1 6 10.0  
 Hispanic or Latino 4 7.3 1 1.7  
 Multiple ethnicity / Other 4 7.3 7 11.7  
 White/Caucasian 33 60.0 39 65.0  
Discipline:      0.58
 Physician 18 32.1 25 41.7  
 Nurse Practitioner 8 14.3 4 6.7  
 Psychologist/Social Worker/Addictions Therapist 10 17.9 9 15.0  
 Pharmacist 9 16.1 12 20.0  
 Nurse 11 19.6 10 16.7  
Specialty:      0.98
 Mental Health 21 37.5 25 41.0  
 Pain Management 16 28.6 17 27.9  
 Primary care/general internal medicine 16 28.6 16 26.2  
 Multiple or Other 3 5.4 3 4.9  
Provider:
 Prescriber
26 46.4 28 45.9 0.95
 DEA Waivered 21 80.8 27 96.4 0.07
Prescribed Buprenorphine for OUD past year 13 61.9 20 74.1 0.37
  1. Mdn Median, DEA Waivered Drug Enforcement Agency Waiver to prescribe MOUD
  2. *p < .05
  3. aBased on Chi Square or Kruskal–Wallis tests for categorical and continuous variables, respectively